ERBB2 and breast cancer: In a subset of datasets, DSCAM-AS1 was significantly overexpressed in BC with lymph node invasion (two datasets), high Ki67 levels (two datasets), HER2 overexpression (two datasets) and when diagnosed in young patients (two datasets).